Integration of pathway and protein-protein interaction (PPI) data can provide more information that could lead to new biological insights. PPIs are usually represented by a simple binary model, whereas pathways are represented by more complicated models. We developed a series of rules for transforming protein interactions from pathway to binary model, and the protein interactions from seven pathway databases, including PID, BioCarta, Reactome, NetPath, INOH, SPIKE and KEGG, were transformed based on these rules. These pathway-derived binary protein interactions were integrated with PPIs from other five PPI databases including HPRD, IntAct, BioGRID, MINT and DIP, to develop integrated dataset (named PathPPI). More detailed interaction type and modification information on protein interactions can be preserved in PathPPI than other existing datasets. Comparison analysis results indicate that most of the interaction overlaps values (O AB ) among these pathway databases were less than 5%, and these databases must be used conjunctively. The PathPPI data was provided at
It is increasingly clear that biological functions are mainly performed through diverse protein interactions. As such, studies on protein interactions have become important undertakings over the last few years [14] . Protein interactions can be mainly obtained from two types of databases: pathway and protein-protein interaction (PPI). Pathway databases contain more diverse interactions, such as signalling, transcription regulation and metabolism, which generally present a clear in vivo interaction type and higher confidence. By contrast, the PPIs from high throughput experiments always feature vague in vivo information and lower confidence.
Studies have shown that large, redundant and complementary information exists in pathway and PPI databases [5, 6] . Integration of these pathways will result in more information that could lead to new biological insights [7] . For example, Ahn et al. [8] , who explored the molecular mechanism and biomarker identification of prostate cancer by integrating diverse pathway and PPI databases, suggested that an integrated network could provide more detailed and interpretable roles of cancer-related genes in prostate cancer cells. Kirouac et al. [9] explored the inflammatory network structure by integrating the GeneGo, Cell MAP, PID and Reactome pathway databases and two other PPI databases. Several attempts have been made to develop databases that integrate pathway and PPI data, such as CPDB [10] and Pathway Commons [11] recently, while previous work fo-1 Materials and methods
Pathway and PPI databases
We mainly focused on pathway databases with the widely used BioPAX standard. In this study, six BioPAX-modelled pathway databases, including PID (contains only the data curated by PID, version 2012.03.17), BioCarta (from PID, version 2010.08.11), Reactome (version 2012.03.14) [18] , NetPath (downloaded 2012.04.14) [19] , INOH (version 2011.01.31) [20] and SPIKE (version 2011.03.22) [21] , were utilized. The non-metabolic pathway portion of KEGG (downloaded 2009.10.12) [22] was also included because of its large data size. The five integrated PPI databases included HPRD (version R9) [23] , IntAct (downloaded 2013. 10.22) [24] , BioGRID (version 3.2.105) [25] , MINT (version 2013.03.26) [26] and DIP (version 2013.07.07) [27] . Integrated databases contained STRING (version 9.1) [28] , Pathway common (downloaded 2014.06.14) and CPDB (downloaded 2014.06.14).
Categorisation of PathPPI
The interaction type of PathPPIs must be depicted in a unified manner. Although PSI-MI provides molecular interaction ontology for PPIs, it cannot fully depict PathPPIs, such as its structured way of indicating the outcome of an interaction. We developed a new categorisation based on BioPAX Level 3 standards and provided eight types of Path-PPI interactions: BiochemicalReactionRegulation (BRR), TransportRegulation (TR), TransportWithBiochemicalReactionRegulation (TBRR), ComplexAssemblyRegulation (CAR), ExpressionRegulation (ER), ComplexAssemblyInteraction (CAI), GeneticInteraction (GI) and MolecularInteraction (MI) ( Table 1 ). The meaning of each types can be obtained through the BioPAX standard [15] and the following transferring rules. Five regulation interactions, including BRR, TR, TBRR, CAR and ER, contain an effect parameter that denotes regulation effects by Activation, Inhibition or Unspecified. BRR and TBRR also contain a modification parameter. A total of 22 common modifications with corresponding de-modifications were included in this work (Table S1 in Supporting Information). Several other rare modifications, such as cholesterol modification, will be added in further versions of our categorisation.
The six PathPPI types, BRR, TR, TBRR, CAR, ER and CAI, are BiolPPIs depicted from a biological perspective and generally with clear in vivo mechanisms. In our categorisation, GI and MI are treated as TechPPIs since they are produced by certain PPI detection technologies and without clear in vivo information.
Transformation of protein interactions from BioPAX into a binary model
BioPAX (Biological Pathway Exchange, http://www.biopax. org/) is a standard language to represent biological pathways at the molecular and cellular level and to facilitate the exchange of pathway data by defining an open file format specification for the exchange of biological pathway data. BioPAX covers all major concepts familiar to biologists studying pathways, including metabolic and signaling pathways, gene regulatory networks and genetic and molec- Figure 1C ). Effect and modification parameters can be obtained from the controlType and interactionType items of Catalysis, respectively. All six pathway databases provide controlType but only NetPath and INOH provide interactionType (Table S2 in Supporting Information). Other than the interactionType approach, we obtained modification information from the changes of protein modification states during BiochemicalReaction in PID and Reactome. For example, if a protein is initially without modification but with phosphorylation after BiochemicalReaction, then we assigned the modification parameter Phosphorylation. For simplicity, in current version we only extracted modification information for the BiochemicalReaction interactions, in which there is only one input entity and its corresponding modification state is output or vice versa ( Figure 1D ). The modification information of the BiochemicalReaction interactions that contain multiple entities were not extracted. Modifications in PID and Reactome were identified by MOD ID [29] . We developed mapping relationships between MOD IDs and PathPPI modification parameters (Table S2 in Supporting Information). BioCarta and SPIKE do not provide modification information. The rules for the Catalysis with other types of Conversion subclasses were similar to that with BiochemicalReaction. TemplateReactionRegulation depicts an interaction in which the controller regulates a TemplateReaction (gene expression) interaction in the BioPAX model. The controller (transcription factor) was defined to have an ER interaction with the products (target genes) of gene expression.
GeneticInteraction and MolecularInteraction are represented in binary form in BioPAX; thus, they were reserved in PathPPI categorisation. Although no GI was extracted from any of the six databases, we reserved GI in the Path-PPI frame for further upgrades. TemplateReaction was ignored because its input and output are always the same. Considering that we focused only on the protein interactions, we discarded the interactions containing interactor of small molecule, non-coding DNA or RNA. If a complex contained small molecules, the proteins were preserved while small molecules were ignored.
Transforming protein interactions from KGML into a binary model
Given that KGML (KEGG Markup Language) adopts a binary-pair model, we can map KGML to PathPPI categories through lexical transformation. KGML categorisation is a two-level hierarchical structure containing four top-level categories: ECrel, PCrel, GErel and PPrel. ECrel depicts an enzyme-enzyme relation that two enzymes catalysing successive reaction steps. PCrel depicts protein-compound interactions. These two types of interaction were discarded. GErel represents the relation of transcription factor and target gene product. GErel has four interaction sub-types: repression, expression, indirect effect and missing interaction. The missing interaction depicts missing interactions in mutation, and it was ignored. The three remaining subtypes have corresponding types in PathPPI. PPrel is the most complicated category in KGML and its subtypes can be classified into three groups. The effect group contains two subtypes, activation and inhibition. The biological event group contains compound, phosphorylation, dephosphorylation, methylation, demethylation, glycosylation, ubiquitination, binding/association and dissociation. Three other subtypes, including state change, missing interaction and indirect effect, were classified as a third group. We developed a mapping relationship between PathPPI categories and all PPrel subtypes except for compound, dissociation, state change and missing interaction. We can obtain PathPPI effects and modification parameters based on the effect and biological event groups, respectively. For example, the interactions of FYN and MAP4K2 are annotated with activation and phosphorylation in KGML, and we assigned the effect and modification parameters of this interaction Activation and Phosphorylation in PathPPI model. More mapping relationships are shown in Table S3 in Supporting Information.
Complex and single models of PathPPIs
The entities (nodes) of interaction in current pathway databases can be complex or family (that is, the node represents multiples proteins), or their more sophisticated combinations, differing from traditional PPIs where the entities are only proteins. Thus, two types of model were proposed in PathPPI to represent binary interactions with complex or family entities ( Figure 1E and F): the complex model, which allows the entities of PathPPIs to be complexes or families, and the single model, which assumes that all the proteins in a complex or family participate in interactions. For example, if a complex with three proteins interacts with another complex with two proteins in the complex model, the corresponding single model will represent 3×2=6 interactions. The complex model is more accurate in depicting real protein interactions, whereas the single model is more convenient for network analysis.
Unification of the protein identifier
Different databases sometimes use different naming systems for gene names. KEGG (human) has its object identifiers (hsa). HPRD uses official gene symbol. BioGRID and SPIKE use gene ID, while the remaining databases (PID, BioCarta, Reactome, NetPath, INOH, IntAct, MINT and DIP) all adopt UniProt AC. For the purpose of reducing redundancy in gene level, we transformed all other heterogeneous IDs to gene symbol utilizing their built-in id mapping systems.
Confidence scores of PathPPI
An existing method, Intscore (http://intscore.molgen. mpg.de/), was used to assign a confidence score for each pairs. IntScore is a web server for confidence scoring of biological interactions. It provides six methods for confidence scoring, as well as the possibility to integrate the method-specific scores. We submitted all PathPPI (single model) to Intscore (default parameter) and obtained their integrated scores for each pairs.
Results
Seven pathway databases were transformed to extract a large number of binary interactions. We combined these pathway-derived binary interactions with traditional PPIs from five other PPI databases into PathPPIs. 
Protein and interaction scales in BiolPPI datasets
First, we searched for the total number of unique proteins represented in the BiolPPI datasets. Results showed that SPIKE contains the highest number of proteins, reaching as high as 3,578. PID, Reactome and KEGG, which have simi- (Table S5 in Supporting Information).
The proportions of the effect parameter Activation are higher than those of Inhibition in all datasets but these proportions were variant. The Activation:Inhibition ratio was approximately 20:1 in PID but less than 2:1 in SPIKE (Table S6 in Supporting Information). Interestingly, many BRRs existed with conflicting annotations in KEGG and SPIKE. For example, the AKT family (AKT1, AKT2 and AKT3) have both activation and inhibition interactions with CHUK, IKBKB and IKBKG. About 85% of the modification parameters were Phosphorylation, followed by Dephosphorylation (~7%), Ubiquitination (~6%) and Acetylation (~1%). No modification information was obtained from SPIKE, BioCarta and Reactome (Table S6 in Supporting Information).
Overlaps among the BiolPPI datasets
We used the index O AB to measure the overlap of sets A and B, which is equal to the arithmetic average of the ratios of the element numbers of (A∩B) divided by sets A and B, respectively [30] . The protein O AB values of each two BiolPPI data sets ranged from 35.74% to 51.29% among the seven pathway datasets, whereas most of the interaction O AB values were less than 5.00% in the complex model (Table 3) and also low in the single model (Table S7 in Supporting Information). These findings indicate that high protein overlaps exist in these datasets but the interaction overlaps are unexpectedly low, considering their common origin of being curated from the literature. This suggests that the coverage of each pathway database is far from complete.
Overlaps between TechPPIs and BiolPPIs
TechPPIs were mainly from high throughput technologies with high false positive rates, while BiolPPIs were generally produced by molecular biological experiments and could be served as real in vivo interactions. Here, we calculated the overlaps of different types of BiolPPIs and TechPPIs, which can represent the real in vivo interaction-detecting capabilities of the high-throughput technologies in some way. We also defined sensitivity to measure the detecting capability of the detection technology, which is equal to the ratio of the element number of (BiolPPI∩TechPPI) divided by BiolPPI group.
BiolPPIs were classified based on their interaction types. TechPPIs annotated with 'two hybrid' (Y2H), 'anti bait co-immunoprecipitation' (ABCoIP) and 'affinity technology' (AffTech) were selected as three technology groups. In addition, interactions with 'in vivo' annotation from HPRD that were mainly detected by small-scale experiments were treated as a control technology group.
Results showed that only a small part of the TechPPIs overlapped with BiolPPIs ( Table 4 ), suggesting that the biological functions of most TechPPIs remain unclear, or the high-throughput experiments have surprisingly high false positive rate. In addition, all of the sensitivity values of three technology groups were very low.
Top degree hub proteins in BiolPPI
In the signalling network (BRR) of BiolPPI, ATM had the highest out-degree (number of directed downstream entities), reaching as high as 849, far more than any other entity. RHOA and RAC1 had the highest in-degree (number of directed upstream entities). In the transcription regulation network (ER) of BiolPPI, TP53 had the highest out-degree (174), whereas KLK3 had the highest in-degree (77). TP53 also has the 3rd highest of in-degree in signalling network, indicating it is a vital transcription factor of jointing the end of signalling cascade and the target genes (Table S8 in Supporting Information). The top-degree proteins in TR, TBRR, CAR and CAI networks were shown in Tables S9S12.
We also examined the contributions of these degrees from the original seven pathway databases. Many of these a) The sensitivity values, which equal to the ratios of the element number of (BiolPPI∩TechPPI) divided by BiolPPI group, are in brackets. AllPPI group contains the PPIs from five PPI databases. The BiolPPIs are depicted in single model. high degree nodes (hubs) were cooperatively contributed from multiple sources other than a dominant one. Especially, out-degree of MAPK1 and in-degree of HRAS#KRAS# NRAS in BiolPPI signalling network were contributed no more than 50% from any original pathway database alone (Figure 2) . The same situations occurred in in-degrees of CDKN1A, MYC, CDKN2A, BCL2 and IL8 in BiolPPI transcription regulation network (Figure 2 ; Table S13 in Supporting Information). The result suggested the necessary of dataset integration.
Comparison with existing databases
We compared our PathPPI categorisation and preserved information with those of Reactome, STRING, CPDB and Pathway Commons (Table 5 ). Reactome developed very simple rules of transforming the protein interaction from pathway to binary model and defined only four interaction types [18] . STRING and CPDB contained six and three interaction types respectively, but both of them did not provide the rules publicly. Pathway Commons developed the most detailed rules and defined nine interaction types to cover as many relationships as possible, such as the CO_CONTROL interaction to depict the relationship of two entities that control the same reaction and SEQUENTIAL_ CATALYSIS for two entities catalyzing two neighbour reactions [11] . PathPPI covered fewer relationship types than Pathway Commons but preserves more information after model transformation, which is very valuable in network analysis. For example, the effect and modification information reserved in PathPPI were missing in all three methods. Another advantage of our PathPPI is that a large amount of traditional PPIs are integrated as TechPPIs.
These five datasets were further divided into subsets based on TechPPI, complex, signaling and transcription interaction (Table 5 ). PathPPI contained four interaction types. STRING and Pathway common contains three types, while Reactome and CPDB had two and one respectively (CPDB did not provide signalling, transcription and complex interactions for downloading). CPDB had the most TechPPT, up to 468,598 ( Figure S1 in Supporting Information). Next were STRING and PathPPI. PathPPI had the most complex and signalling interactions. The interaction O AB values of each two interaction data sets ranged from Figure 2 Degrees of the seven nodes that from top 10 signalling or transcription regulation degree list, and are with no more 50% from any original pathway database alone. 
An example in disease genes identification
Screening of genes resulting in specific diseases has long been one of the major tasks in human genetics studies. ) from BRR and ER interaction network respectively in Ye's dataset (Table S15 in Supporting Information). and 5, 0 subnetworks (P<10
5
) in Zhang dataset (Table S16 in Supporting Information). Furthermore, we found that three subnetwork containing at least two known metastasis-association genes ( Figure 3 ). These three subnetworks can be paid more attention in further research.
Discussion
Integration of pathway and PPI data can provide more information that could lead to new biological insights. Considering that pathways and PPIs are generally represented by different standards, model transformations are inevitable. One solution to this problem is to transform pathway into binary models. In this study, we developed a series of rules to realise such transformations. Some important information of interactions that is always neglected in earlier studies, such as modification information, is preserved in PathPPI.
A categorisation was established to depict pathwayderived binary interactions and traditional PPIs. Similar to the Reactome, STRING and Pathway Commons categorisations, PathPPI categorisation is also not fully systematic, but it is helpful to deal with current pathway data. A more systematic categorisation based on biological events is desired. In addition, a number of special relationships (e.g., CO_ CONTROL in Pathway Commons) in BioPAX that are not extracted in the current PathPPI version will be considered in our future work.
Two fundamental problems exist in the transformation of interactions from the pathway model to the binary model. One is the lack of efficient transformability between the pathway and PPI models. BioPAX and PSI-MI are the mainstream standards of pathways and PPIs, respectively. Although BioPAX is designed to contain all PSI-MI functions, it does not consider transformability with PSI-MI. Multiple data models will inevitably exist for respective advantages and suitable fields. Thus, the efficient transformability between BioPAX and PSI-MI should be improved. Another problem is that some pathway databases do not provide enough information or show divergent use of standards. For example, Reactome and PID do not provide the conversionType items of BiochemicalReaction and Bio- Figure 3 Three co-expression modules with known cancer metastasis genes. Known cancer metastasis and down-regulated genes were marked by "*" and "" respectively. The color represented the -log of P values of each gene (rank-sum test). ADAM17, EGFR, HBEGF, IGF1R, MMP9, PLD2, and VEGFB in the second module were associated with cell migration (Gene Ontology).
Carta and SPIKE do not contain modification information in the BioPAX model. The divergent use of BioPAX may bring about errors or information loss. For example, the interaction, that a set of physical entities aggregated via non-covalent interactions, should be depicted by ComplexAssembly, but it is BiochemicalReaction in Reactome. The latter should be used to depict covalent reactions.
We propose a combination of the complex and single models to represent PathPPIs. The entity in complex models may be very complicated, for example, the entity GGT1*GGT1#GGT2*GGT2#GGT5*GGT5#GGT6*GGT6 #GGT7*GGT7 in Reactome, which represents a protein complex family (the marks * and # are used to separate the members of the complex and family, respectively). The complex model is more accurate in interaction description but inconvenient for analysis. The single model is convenient for analysis but an inaccurate and cumbersome approach for depicting interactions. We thus recommend the complex model equipped with corresponding data extracting methods.
Conclusion
This study aimed to provide a method to standardise the integration of pathway and PPI data. We obtained numerous BiolPPIs by transformation of seven pathway databases that are highly complementary with traditional PPIs. These BiolPPIs were integrated with traditional PPIs (TechPPIs) into the PathPPI dataset, which can provide great knowledge with hierarchical information content and confidence. Although PathPPI requires further improvement because of data source constraints, it is a starting point for the standardisation of pathway and PPI data integration. More complete standardisation requires collaboration from communities around the world.
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